GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Coral Laboratories Ltd

Coral Laboratories Ltd receives MSMED Act Section 18 notice — legal matter

REGULATORY ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 27 Apr 2026, 11:49 AM IST  ·  BSE ID: 6ca54e4e-9a22-4452-b5ad-bad955ca7454
View Original BSE Filing (PDF)
💡
In Simple Terms
A supplier has filed a complaint against the company claiming unpaid dues under the small business protection law.
🤖 AI Summary
  • Coral Laboratories Ltd received notice under Section 18 of MSMED Act, 2006
  • Section 18 invoked by supplier for alleged non-payment or delayed payment of dues
  • Notice initiates statutory dispute resolution and reconciliation mechanism
  • Filing amount, supplier identity, and dispute details not disclosed in notice announcement
  • First regulatory disclosure from company since no prior filing history available
🔢 Key Numbers - exact figures from BSE filing, not rounded
Amount in dispute
Not disclosed in notice
🏢 How This Affects the Company
📈
Business Impact
Supplier relationship is in dispute. If dues are confirmed, the company faces payment obligation that affects working capital and vendor credit terms.
💰
Financial Impact
Depending on amount and outcome, the company may incur cash outflow, interest penalties under MSMED Act (1.5% per month on overdue amount), or contingent liability if amount is material.
⚙️
Operational Impact
Disputed supplier may restrict further credit or deliveries, disrupting supply chain unless dispute is resolved quickly.
⚠️
Risk Impact
MSMED Act Section 18 disputes can escalate to arbitration and recovery proceedings. Non-compliance with reconciliation orders carries legal and reputational risk.
👥 What This Means For Shareholders
✅
Action Required
Monitor next quarterly filings or BSE announcements for updates on dispute resolution, settlement amount, or escalation to arbitration.
👤
Who Is Affected
All shareholders are affected if the undisclosed amount is material to the balance sheet. Payment obligations reduce distributable cash and affect solvency ratios.
🔍
Management Signal
Disclosure indicates compliance with BSE listing requirements but lack of detail suggests the company is treating this as a routine vendor dispute rather than a material event.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q4 FY26 results — check contingent liabilities note for MSMED dispute disclosure
BSE announcement — company's formal reply or reconciliation update within 60 days
Supplier arbitration filing — track if dispute escalates beyond Section 18 mechanism
MEDIUM RISK MSMED Section 18 disputes carry mandatory reconciliation timeline and interest penalties. Undisclosed amount prevents full risk quantification.
💡 Investor Takeaway
Coral Laboratories Ltd received a formal notice under MSMED Act Section 18 from a supplier claiming unpaid dues. Filing does not disclose the amount, timeline of alleged non-payment, or supplier identity. The statutory mechanism requires the company to participate in reconciliation. Materiality and company response remain unknown.
⚖️ Strengths & Concerns

⚠️ Concerns

  • No disclosure of amount in dispute, preventing investors from assessing financial materiality.
  • Section 18 notice indicates payment dispute with supplier — suggests working capital management or cash flow strain.
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel